Related Experiment Video
Updated: Jun 2, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Nontuberculous mycobacterial infections].
Emilie Catherinot1, Jean-Louis Gaillard, Louis-Jean Couderc
1Université Versailles-Saint-Quentin, service de pneumologie, hôpital Foch, 92150 Suresnes. emilie.catherinot@nck.aphp.fr
Nontuberculous mycobacteria (NTM) infections are rising due to more at-risk patients and better diagnostics. This review covers NTM classification, clinical features, and treatment strategies for healthcare providers.
Area of Science:
- Microbiology
- Infectious Diseases
Context:
- Nontuberculous mycobacteria (NTM) represent a diverse group of species with varying human pathogenicity.
- NTM infections are increasingly recognized globally.
- Factors contributing to this rise include an increasing number of immunocompromised patients, advancements in microbiological diagnostic techniques, and potentially increased environmental exposure.
Purpose:
- To provide a comprehensive overview of NTM classification.
- To detail the clinical manifestations of NTM infections.
- To outline current treatment approaches for NTM diseases.
Summary:
- This article classifies Nontuberculous Mycobacteria (NTM).
- It elaborates on the clinical presentation of diseases caused by NTM.
- It discusses the therapeutic strategies for managing NTM infections.
Impact:
- Equips clinicians with essential knowledge regarding NTM classification, clinical spectrum, and treatment.
- Aids in the timely diagnosis and effective management of NTM infections.
- Contributes to improved patient outcomes in the growing field of NTM disease.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

